Federal affordable housing incentive faces a Des Moines pause
Why it matters: The LIHTC is one of the country's most common tools for creating affordable housing, giving local and state governments billions of dollars in annual budget authority.
Advocates say LIHTC-funded projects drive development, while critics contend the program creates an unequal distribution of poverty in some areas.
Catch up quick: The LIHTC program, administered by the IRS and state agencies, provides tax credits to developers in exchange for maintaining affordable housing, usually for 10 to 15 years.
Projects typically require approval from local governments before they are awarded incentives.
By the numbers: As of January, DSM had 90 projects using the LIHTC to provide more affordable rents for low-income families, according to a report by the Iowa Economic Development & Finance Authority.
West Des Moines had eight, Johnston had four, Ankeny had three, and Urbandale had one.
State of play: DSM is developing its first comprehensive citywide housing strategy, which will shape the allocations of the LIHTC and other incentives for future projects.
Charles Buki, president of Maine-based urban planning firm CZB, recommended the LIHTC pause, saying that developers can exploit the system in deals that don't always benefit the city in boosting its tax base as much as other types of projects.
He recommends the city boost allocations to Invest DSM and Improving Our Neighborhoods (ION).
The big picture: The debate over the usefulness of the LIHTC continues, with groups like the Cato Institute testifying before a congressional oversight subcommittee this month that it is an inefficient solution to housing affordability.
What they're saying: Councilperson Josh Mandelbaum said a pause on using the LIHTC "abdicates Des Moines' responsibility to provide affordable housing" and would have prevented recent projects like Star Lofts along Ingersoll.
Councilperson Joe Gatto, however, said residents in his south-side ward are becoming weary of having LIHTC projects in their backyards.
"I bet if there was a project that came forward south of Grand, your neighbors might feel a little bit different," Gatto told Mandelbaum during last week's meeting.
Zoom in: Matt Hauge, spokesperson for the Polk County Housing Trust Fund, tells Axios that the LIHTC plays a vital role in revitalizing neighborhoods and supporting economic development and that a blanket cessation of its use in DSM "is just a bad idea."
Developer and former state Sen. Jack Hatch tells Axios that the proposal to pause the LIHTC is "misinformed" and rooted in a "lack of knowledge of housing finance."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
11 minutes ago
- San Francisco Chronicle
Zeekr: Q2 Earnings Snapshot
NINGBO, China (AP) — NINGBO, China (AP) — Zeekr Intelligent Technology Holding Ltd. (ZK) on Thursday reported a loss of $55 million in its second quarter. The Ningbo, China-based company said it had a loss of 21 cents per share. Losses, adjusted for stock option expense, came to 20 cents per share. The electric vehicle maker posted revenue of $3.83 billion in the period.
Business Insider
43 minutes ago
- Business Insider
$5.3 billion Abridge wants to make acquisitions. Here's what the healthcare AI startup is looking for.
Abridge is on a hot streak. Now, as the healthcare startup competes in the AI talent wars, it's preparing to go on a shopping spree. Abridge, which builds AI-powered software to transcribe and summarize patient-doctor conversations, landed a $300 million round in June led by Andreessen Horowitz. It was its second mega-raise in four months; the company had raked in a $250 million round in February. In 18 months, Abridge has raised $700 million in total and boosted its valuation from $850 million to $5.3 billion. Abridge CEO and cofounder Dr. Shiv Rao has big plans for all of that capital, he told Business Insider. "We've got a lot of money in the bank, and we want to spend 80% of it just going deeper, and expanding from connecting conversations to clinical notes into claims, clinical decision support, and care management," he said. With 80% of its cash reserved for doubling down on its tech, Abridge is earmarking the remaining 20% for potential acquisitions, Rao said. Those deals are looking increasingly critical in the brutal, competitive landscape of ambient healthcare scribes. Perhaps the most gutting release is set to come from Epic, the electronic health record giant that first partnered with Abridge back in 2023 in a watershed moment for the startup. Epic is now gearing up to launch an AI scribe of its own, Politico reported this month. Abridge declined to comment on the reports. Epic didn't respond to requests for comment. Epic's launch would follow healthcare startup Ambience, Abridge's biggest direct competitor, raising its own mega-round this summer. Ambience's $250 million Series C was co-led by Oak HC/FT and A16z, a longtime investor in Ambience that appears to be double-dipping in AI scribing with its growth investment in Abridge. And, as Abridge works to expand beyond scribing to use AI for tasks like processing medical bills, it's running up against private equity firms like New Mountain Capital pouring billions into their healthcare AI plays. Abridge has remained a frontrunner as the pressure builds. It's now working with over 150 large health systems, Rao said. The startup is also partnering closely with some of those health systems on its new products — Abridge said Tuesday it's collaborating with Pittsburgh health system Highmark Health on tech to automate prior authorization requests. And Abridge is focusing squarely on the patient-provider conversation as the starting point for each of its new tools or acquisition targets, Rao said. "The last thing we want to do is to become a company that's opening up a trench coat and selling you random things that have no coherence to our mission," he said. "But if there are things that are absolutely on our road map, it would be smart for us to have open ears." Eyeing fresh talent and tech As San Francisco-based Abridge has landed fundraise after fundraise, many startups hoping to get acquired by Abridge have entered Rao's inbox. While Rao said Abridge isn't "in talks" with any particular company, it's prepared to notch deals to grow faster. The startup hasn't made any acquisitions since its 2018 founding. "It feels like a lot of companies are asking if they can join us in some way. We need to be able to spend on things like that — data plays, ecosystem plays, and partnerships," Rao said. Acquiring top talent is Abridge's biggest priority, Rao said, adding that the startup has been competing with AI giants like OpenAI and Anthropic in its recent hiring efforts. The AI talent wars are raising the stakes for startups like Abridge. As Big Tech companies fight over top AI researchers, including by offering pay packages in the millions or tens of millions, startups are touting their mission-centric approaches to convince engineers to join their teams over tech giants. Rao thinks Abridge can compete effectively for AI talent by offering hires the rare chance to build tools that matter, tech that actually improves people's health. "Finding ways to recruit more world-class talent as fast as possible is really, really important for us," he said. "If this is the legacy you want to leave, if you want to be a part of a company where every single day you can feel really good that you improved patient care, then we're going to resonate more than those horizontal technology companies." Abridge has about 330 employees, a number Rao is aiming to increase massively, especially in its engineering department, though he says the company won't rely exclusively on M&A to do that. Abridge builds its own large-language models that its widening suite of software sits upon. Those models make up its "contextual reasoning engine," which automates clinical notetaking that can combine ambient scribing with relevant context from the patient's existing health records and generate actionable outputs like medical orders and suggested billing codes. Rao said Abridge is considering buying data where necessary to continue training its models. With a combination build-and-buy strategy, Abridge is moving further into revenue cycle management, the hottest ticket item in healthcare AI, since it aims to help health systems capture more revenue while saving time for doctors. Rao said Abridge is also working on areas like risk adjustment, the process of estimating a patient's expected medical costs, that is critical for value-based care arrangements, and care coordination. Abridge wants to dig deeper into clinical decision support, too, a field that many healthcare startups have stayed away from, as the tech often walks a thin line to avoid facing FDA regulations. Abridge first stepped into the space in October by partnering with medical insights company UpToDate to surface relevant clinical evidence in Abridge's generated notes. Rao said he expects Abridge to share more information from the partnership later this year. As Abridge looks to take over more tasks for doctors, the company is being deliberate about how and when it'll meet "good friction" like FDA regulation, Rao said. "As we move into higher-stakes workflows from a patient outcomes perspective, we have to be really, really responsible," he said. "We try to be as transparent as we possibly can on how our models work and how we evaluate them. We'll need to continue to be transparent as we get into those new spaces."
Business Insider
43 minutes ago
- Business Insider
NetBox Labs raised $35 million amid an AI-driven infrastructure boom. See the pitch deck it used to land its Series B funding.
New York City-based NetBox Labs was cofounded in 2023 by CEO Kris Beevers as the for-profit steward of 10-year-old NetBox, an open-source network and infrastructure platform used by tens of thousands of companies globally. NetBox Labs offers five products built on top of the open-source software with advanced features to make it easier to run, Beevers said, including additional security and support, automation tools, and an AI assistant. It makes money by charging subscriptions based on the tools used and the size of a client's infrastructure. Sorenson Capital and Headline participated in the round, as did existing investors Flybridge Capital, Notable Capital, Mango Capital, Salesforce Ventures, Two Sigma Ventures, and IBM. The company had previously raised $20 million in Series A funding. AI is fueling demand for infrastructure services, and NetBox Labs' revenue is in the single-digit millions, Beevers said. It reinvests a "big chunk" back into the open-source tool. The company has roughly 200 customers, including AI data center giant CoreWeave, for whom it helps manage data center configurations and design future facilities. It also works with non-AI-focused companies, whose infrastructure has become more complex and dynamic amid ongoing digitization in recent years, Beevers said. This includes departments of transportation across the country — managing toll booths, speed cameras, and more— as well as ARM, Cisco, Constant Contact, J.P. Morgan, Kaiser Permanente, and Riot Games. The investment will be used to hire across engineering and sales. Beevers said the company will surpass 100 employees this year. Beevers previously served as the cofounder and CEO of NS1, which spun out NetBox Labs after selling the other part of its business to IBM in 2023. Jeremy Stretch, the creator of NetBox, also serves as a cofounder at NetBox Labs. Here's a look at the pitch deck the startup used to raise its $35 million Series B. Certain slides have been edited and removed so that the deck can be shared publicly. Network and Infrastructure Management Is Growing More Painful, Exponentially NetBox = Leverage to Massive Platform Play NetBox Wins in an AI World
